The higher accumulation of IgM in BXPC3 tumor masses shown in-vivo and ex-vivo in mice treated with AT101 compared to mice treated with unspecific IgM was also confirmed by IF by evaluating explanted tumor masses after 96 h, both visualizing the figures or analyzing fluorescence signal in the different samples (Fig. 4A). Here, CD40LG is linked to neoplasm.